Evidence map›Paper›PMID 36509852›Full record

ArticleNature chemistry2023

Enantioselective synthesis of atropisomeric indoles via iron-catalysed oxidative cross-coupling.

Richard R Surgenor, Xiangqian Liu, Morgan J H Keenlyside, William Myers, Martin D Smith

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Installing Axial Chirality by Atroposelective C(spJournal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Atroposelective catalysis.Nature reviews. Chemistry · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richard R SurgenorChemistry Research Laboratory, University of Oxford, Oxford, UK.
Xiangqian LiuChemistry Research Laboratory, University of Oxford, Oxford, UK.
Morgan J H KeenlysideChemistry Research Laboratory, University of Oxford, Oxford, UK.
William MyersInorganic Chemistry Laboratory, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5935-9112
Martin D SmithChemistry Research Laboratory, University of Oxford, Oxford, UK. martin.smith@chem.ox.ac.uk.ORCID http://orcid.org/0000-0002-8849-488X

Funding

RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/L011972/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/L015838/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/R005826/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V036408/1
6 · The paper itself

Abstract

Heterobiaryl compounds that exhibit axial chirality are of increasing value and interest across several fields, but direct oxidative methods for their enantioselective synthesis remain elusive. Here we disclose that an iron catalyst in the presence of a chiral PyBOX ligand and an oxidant enables direct coupling between naphthols and indoles to yield atropisomeric heterobiaryl compounds with high levels of enantioselectivity. The reaction exhibits remarkable chemoselectivity and exclusively yields cross-coupled products without competing homocoupling. Mechanistic investigations enable us to postulate that an indole radical is generated in the reaction but that this is probably an off-cycle event, and that the reaction proceeds through formation of a chiral Fe-bound naphthoxy radical that is trapped by a nucleophilic indole. We envision that this simple, cheap and sustainable catalytic manifold will facilitate access to a range of heterobiaryl compounds and enable their application across the fields of materials science, medicinal chemistry and catalysis.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.